Literature DB >> 7905617

The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors.

R G Hawley1, A Z Fong, M Lu, T S Hawley.   

Abstract

The t(10;14) chromosomal translocation of T-cell acute lymphoblastic leukemia joins the T-cell receptor delta gene to a region upstream of a diverged homeobox-containing gene called HOX11. To better understand the pathogenetic role of HOX11 in leukemogenesis, post 5-fluorouracil-treated murine bone marrow cells were infected with a replication-defective retrovirus bearing the gene. Constitutive expression of HOX11 in hematopoietic precursors yielded cell lines at high frequency consisting of immature cells belonging to the myeloid lineage. HOX11-transformed cell lines displayed a strict dependence on IL-3 for their survival and proliferation in culture and were not leukemogenic. The results support the hypothesis that the transforming capacity of HOX11 derives from its ability to alter the expression of genes regulating hematopoietic differentiation and that secondary mutations promoting cell survival or stimulating proliferation are required for progression to malignancy. The findings further suggest that the oncogenic activity of HOX11 might not be restricted to T-cell leukemias in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905617

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Distinct domains of the GATA-1 cofactor FOG-1 differentially influence erythroid versus megakaryocytic maturation.

Authors:  Alan B Cantor; Samuel G Katz; Stuart H Orkin
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

3.  Optimal activation of an endogenous gene by HOX11 requires the NH2-terminal 50 amino acids.

Authors:  N Masson; W K Greene; T H Rabbitts
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Reducing the genotoxic potential of retroviral vectors.

Authors:  Ali Ramezani; Teresa S Hawley; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2008

5.  Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells.

Authors:  D S Pereira; C Dorrell; C Y Ito; O I Gan; B Murdoch; V N Rao; J P Zou; E S Reddy; J E Dick
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

6.  NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.

Authors:  E Kroon; U Thorsteinsdottir; N Mayotte; T Nakamura; G Sauvageau
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

7.  Apoptotic role of IKK in T-ALL therapeutic response.

Authors:  Irene Riz; Lynnsey A Zweier-Renn; Ian Toma; Teresa S Hawley; Robert G Hawley
Journal:  Mol Cancer Res       Date:  2011-07-05       Impact factor: 5.852

8.  Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

Authors:  R G Hawley; T S Hawley; A Z Fong; C Quinto; M Collins; J P Leonard; S J Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1.

Authors:  Edwin Chen; Xiaoyong Huang; Yanzhen Zheng; You-Jun Li; Alden Chesney; Yaacov Ben-David; Eric Yang; Margaret R Hough
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

10.  c-Jun homodimers can function as a context-specific coactivator.

Authors:  Benoit Grondin; Martin Lefrancois; Mathieu Tremblay; Marianne Saint-Denis; André Haman; Kazuo Waga; André Bédard; Daniel G Tenen; Trang Hoang
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.